首页> 外文期刊>癌と化学療法 >A case of extraovarian primary peritoneal carcinoma successfully treated with weekly paclitaxel
【24h】

A case of extraovarian primary peritoneal carcinoma successfully treated with weekly paclitaxel

机译:与每周紫杉醇成功治疗其他骨髓癌癌的情况

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

We report the use of paclitaxel in the successful treatment of a 74-year-old patient with extraovarian primary peritoneal carcinoma and acute renal failure caused by intraperitoneal cisplatin. The histological diagnosis was papillary serous adenocarcinoma. Paclitaxel was given intravenously at 70 mg/m2 in a 1-hour infusion weekly for 6 consecutive weeks followed by 2-weeks rest (one cycle). Toxicities including neutropenia and neurotoxicity were mild. She showed a clinical response after three cycles, and then underwent secondary cytoreductive surgery after which she received one additional cycle of therapy. She enjoyed a favorable quality of life without evidence of disease for 16 months after the completion of this therapy. Weekly 1-hour paclitaxel (70 mg/m2) was well tolerated, yet was effective for extraovarian primary peritoneal carcinoma.
机译:我们举报了紫杉醇在成功治疗74岁的患者与腹膜内顺铂引起的急性原发性腹膜癌和急性肾功能衰竭的成功处理。 组织学诊断是乳头状浆液性腺癌。 紫杉醇在每周一次输注60mg / m 2时静脉内给药,连续6周,然后休息2周(一个循环)。 毒性包括中性粒细胞减少和神经毒性的毒性。 她在三个循环后表现出临床反应,然后接受了继发性细胞功能性手术,后她接受了一个额外的治疗循环。 在完成此疗法后16个月,她享有有利的生活质量,没有疾病的证据。 每周1小时紫杉醇(70mg / m 2)耐受良好,但对于非律师原发性腹膜癌是有效的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号